Patent · US Active

Pre-saturation of the liver and subsequent administration of the contrast agent

US10786583B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

B. Braun Melsungen AG · DE

Inventors

Thore Dietrich · Berlin, DE
Riad Bourayou · Berlin, DE
Eckart Fleck · Berlin, DE
Thorsten Keller · Neupotz, DE
Jürgen Schmitt · Kirchhain, DE
Doris Röthlein · Kassel, DE

Key dates

Filing date	Sep 25, 2014
Grant date	Sep 29, 2020
Priority date	—
Expiry date	Feb 6, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K49/0471
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to an aqueous formulation for use in diagnostic detection wherein the aqueous formulation is administered prior to the administration of a fluorinated contrast agent or composition comprising a fluorinated contrast agent as well as to a method of administration. The invention further relates to the use of said aqueous formulation for the diagnostic detection of inflammatory pathological conditions using MR imaging. In addition the invention relates to a kit as well as a diagnostic kit suitable for use in diagnostic detection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.